I am currently a student in a Regulatory Science Masters programme, with the ultimate goal of making safe pharmaceuticals accessible to those who need them the most. I currently work in women's health, primarily in ovarian cancer and endometriosis research, and I see how many women are affected by these diseases - it is my hope that through my work, I will be able to work with those who are developing tumour biomarkers to prevent disease progression. We must take into account the fact that the top pharmaceuticals are often inaccessible to those from low income backgrounds, and while we may be making progress on the disease front, we need to come up with equitable ways for women and people of colour to be heard and believed when it comes to their diseases. Many reports have shown that disease can go undetected in these groups simply because their healthcare providers don't recognise the level of pain they are in. Especially working in women's health, we see how many doctors women have to go through before they are given an accurate diagnosis; some women see more than 15 doctors before they are truly listened to. As a professional in regulatory affairs, my hope is to bridge the gap between clinicians, patients, and pharmaceutical companies to discuss solutions that work best for everyone, and ultimately be on the ground, providing medical access to those who may not get treatment otherwise. While I may not be a medical professional, over my years as a volunteer, student intern, and employee within the hospital systems in Boston, I see how we all play a vital role in cancer prevention and health equity.